Takeda Pharmaceutical Company Limited (TAK) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Sales/Revenue | 1.11T | 1.21T | 1.11T | 1.11T | 1.05T | 1.14T | 1.18T | 1.21T | 1.05T | 1.11T | 1.04T | 1.06T | 956.16B | 1.1T | 1T | 972.47B | 873.29B | 901.29B | 844.82B | 949.6B |
| Revenue Growth % | 5.81% | 6.04% | -5.38% | -8.39% | 0.24% | 2.96% | 12.75% | 14.11% | 9.91% | 1.33% | 4.07% | 8.86% | 9.49% | 21.66% | 18.64% | 2.41% | 13.37% | 7.71% | 7.08% | 18.43% |
| Cost of Goods Sold | 570.84B | 552.87B | 380.06B | 384.68B | 382.1B | 416.87B | 394.31B | 386.95B | 387.33B | 379.48B | 343.58B | 321.11B | 309.77B | 335.97B | 305.44B | 292.88B | 308.38B | 281.4B | 275.8B | 241.26B |
| COGS % of Revenue | 51.21% | 45.57% | 34.15% | 34.76% | 36.27% | 36.44% | 33.53% | 32.03% | 36.86% | 34.15% | 32.94% | 30.33% | 32.4% | 30.64% | 30.47% | 30.12% | 35.31% | 31.22% | 32.65% | 25.41% |
| Gross Profit | 543.81B | 660.35B | 732.74B | 722.01B | 671.3B | 727.25B | 781.73B | 821.04B | 663.54B | 731.71B | 699.51B | 737.5B | 646.38B | 760.58B | 696.86B | 679.58B | 564.91B | 619.89B | 569.02B | 708.34B |
| Gross Margin % | 48.79% | 54.43% | 65.85% | 65.24% | 63.73% | 63.56% | 66.47% | 67.97% | 63.14% | 65.85% | 67.06% | 69.67% | 67.6% | 69.36% | 69.53% | 69.88% | 64.69% | 68.78% | 67.35% | 74.59% |
| Gross Profit Growth % | -18.99% | -9.2% | -6.27% | -12.06% | 1.17% | -0.61% | 11.75% | 11.33% | 2.65% | -3.8% | 0.38% | 8.52% | 14.42% | 22.7% | 22.47% | -4.06% | 9.3% | 6.22% | 5.51% | 25.64% |
| Operating Expenses | 496.27B | 466.28B | 663.74B | 537.44B | 746.2B | 660.31B | 597.48B | 654.71B | 673.61B | 626.79B | 748.85B | 568.93B | 557.82B | 613.59B | 592.42B | 529.07B | 566.53B | 503.4B | 471.6B | 459.79B |
| OpEx % of Revenue | 44.52% | 38.43% | 59.65% | 48.56% | 70.84% | 57.71% | 50.8% | 54.2% | 64.1% | 56.41% | 71.79% | 53.74% | 58.34% | 55.96% | 59.11% | 54.4% | 64.87% | 55.85% | 55.82% | 48.42% |
| Selling, General & Admin | 297.36B | 287.89B | 253.55B | 255.88B | 295.9B | 270.59B | 268.28B | 270.03B | 285.23B | 267.52B | 252.95B | 248.11B | 254.8B | 262.3B | 248.73B | 231.48B | 223.43B | 231.08B | 212.01B | 219.84B |
| SG&A % of Revenue | 26.68% | 23.73% | 22.79% | 23.12% | 28.09% | 23.65% | 22.81% | 22.35% | 27.14% | 24.08% | 24.25% | 23.44% | 26.65% | 23.92% | 24.82% | 23.8% | 25.58% | 25.64% | 25.1% | 23.15% |
| Research & Development | 198.91B | 178.39B | 161.48B | 143.89B | 216B | 170.19B | 175.56B | 168.46B | 195.86B | 187.38B | 183.95B | 162.74B | 160.94B | 174.63B | 154.15B | 143.61B | 143.63B | 128.38B | 131.6B | 122.48B |
| R&D % of Revenue | 17.84% | 14.7% | 14.51% | 13% | 20.51% | 14.88% | 14.93% | 13.95% | 18.64% | 16.86% | 17.63% | 15.37% | 16.83% | 15.93% | 15.38% | 14.77% | 16.45% | 14.24% | 15.58% | 12.9% |
| Other Operating Expenses | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 47.54B | 194.06B | 69B | 184.57B | -74.9B | 66.94B | 184.25B | 166.33B | -10.07B | 104.91B | -49.34B | 168.57B | 88.56B | 146.99B | 104.44B | 150.51B | -1.62B | 116.48B | 97.43B | 248.55B |
| Operating Margin % | 4.27% | 16% | 6.2% | 16.68% | -7.11% | 5.85% | 15.67% | 13.77% | -0.96% | 9.44% | -4.73% | 15.92% | 9.26% | 13.4% | 10.42% | 15.48% | -0.19% | 12.92% | 11.53% | 26.17% |
| Operating Income Growth % | 163.47% | 189.9% | -62.55% | 10.96% | -643.87% | -36.19% | 473.42% | -1.33% | -111.37% | -28.63% | -147.24% | 12% | 5570.17% | 26.19% | 7.2% | -39.44% | -101.08% | -18.62% | 101.7% | 48.58% |
| EBITDA | 214.42B | 388.14B | 274.15B | 366.2B | 114.87B | 253.9B | 376.7B | 358.55B | 93.13B | 291.98B | 190.9B | 340.07B | 249.97B | 323.87B | 272.26B | 308.8B | 150.66B | 263.77B | 238.07B | 391.5B |
| EBITDA Margin % | 19.24% | 31.99% | 24.64% | 33.09% | 10.9% | 22.19% | 32.03% | 29.68% | 8.86% | 26.28% | 18.3% | 32.12% | 26.14% | 29.54% | 27.16% | 31.75% | 17.25% | 29.27% | 28.18% | 41.23% |
| EBITDA Growth % | 86.67% | 52.87% | -27.22% | 2.13% | 23.34% | -13.04% | 97.33% | 5.43% | -62.74% | -9.85% | -29.88% | 10.13% | 65.92% | 22.79% | 14.36% | -21.12% | -48.04% | -6.76% | 27.14% | 26.75% |
| D&A (Non-Cash Add-back) | 166.88B | 194.08B | 205.16B | 181.64B | 189.77B | 186.96B | 192.45B | 192.22B | 103.2B | 187.06B | 240.24B | 171.5B | 161.41B | 176.88B | 167.83B | 158.28B | 152.27B | 147.28B | 140.65B | 142.95B |
| EBIT | 47.54B | 262.14B | 111.31B | 257.79B | -8.5B | 6.05B | 187.83B | 196.29B | 156.03B | 69.97B | -37.96B | 194.61B | 38.12B | 186.9B | 118.35B | 210.94B | -20.87B | 118.9B | 101.12B | 294.05B |
| Net Interest Income | -39.2B | -36.4B | -38.74B | -33.4B | -207.21M | -207.35M | -64.34B | -29.01B | -277.45M | -44.78B | -336.63M | -33.12B | -265.49M | -38.07B | -39.02B | 5.46B | -24.26B | -42.56B | -32.81B | -25.22B |
| Interest Income | 5.25B | 89.46B | 44.4B | 73.76B | 122.99M | 0 | 4.12B | 30.68B | 40.36M | 21.79B | 64.74M | 26.45B | 58.79M | 41.68B | 14.78B | 60.92B | 0 | 4.14B | 6.86B | 45.85B |
| Interest Expense | 44.45B | 125.86B | 83.14B | 107.16B | 330.2M | 207.35M | 68.45B | 59.69B | 317.81M | 66.57B | 401.37M | 59.58B | 324.28M | 79.75B | 53.8B | 55.47B | 24.26B | 46.71B | 39.68B | 71.07B |
| Other Income/Expense | -100.98B | -57.78B | -40.82B | -33.94B | -32.4B | -40.53B | -64.88B | -29.73B | -37.45B | -43.65B | -46.64B | -33.12B | -40.65B | -39.84B | -39.02B | 5.46B | -52.43B | -44.29B | -35.98B | -25.57B |
| Pretax Income | -53.44B | 136.28B | 28.17B | 150.63B | -107.3B | 26.41B | 119.37B | 136.6B | -47.52B | 61.26B | -95.98B | 135.45B | 47.91B | 107.15B | 65.42B | 155.97B | -54.05B | 72.19B | 61.45B | 222.98B |
| Pretax Margin % | -4.79% | 11.23% | 2.53% | 13.61% | -10.19% | 2.31% | 10.15% | 11.31% | -4.52% | 5.51% | -9.2% | 12.8% | 5.01% | 9.77% | 6.53% | 16.04% | -6.19% | 8.01% | 7.27% | 23.48% |
| Income Tax | -28.74B | 30.67B | 39.9B | 26.35B | -4.2B | 2.57B | 27.27B | 41.3B | -44.53B | -44.5B | -48.01B | 45.63B | 16.78B | -12B | 2.82B | 50.45B | -42.67B | 14.37B | 15.45B | 85.25B |
| Effective Tax Rate % | 53.78% | 22.51% | 141.63% | 17.49% | 3.91% | 9.74% | 22.84% | 30.24% | 93.7% | -72.63% | 50.02% | 33.69% | 35.02% | -11.2% | 4.31% | 32.35% | 78.95% | 19.91% | 25.15% | 38.23% |
| Net Income | -24.77B | 105.51B | -11.8B | 124.24B | -103.2B | 23.79B | 92.05B | 95.25B | -3.02B | 105.72B | -48.03B | 89.39B | 31.13B | 119.13B | 61.74B | 105.01B | -11.36B | 57.77B | 45.96B | 137.68B |
| Net Margin % | -2.22% | 8.7% | -1.06% | 11.23% | -9.8% | 2.08% | 7.83% | 7.88% | -0.29% | 9.51% | -4.6% | 8.44% | 3.26% | 10.86% | 6.16% | 10.8% | -1.3% | 6.41% | 5.44% | 14.5% |
| Net Income Growth % | 76% | 343.52% | -112.82% | 30.44% | -3319.48% | -77.5% | 291.64% | 6.55% | -109.69% | -11.25% | -177.79% | -14.87% | 374.12% | 106.21% | 34.33% | -23.73% | -105.76% | -37.45% | 1038.57% | 66.87% |
| Net Income (Continuing) | -24.7B | 105.61B | -11.73B | 124.28B | -103.1B | 23.84B | 92.11B | 95.3B | -2.99B | 105.76B | -47.97B | 89.82B | 31.14B | 119.15B | 62.6B | 105.52B | -11.38B | 57.82B | 45.99B | 137.73B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1.21B | 1.15B | 992M | 921M | 895M | 917M | 843M | 815M | 741M | 673M | 673M | 617M | 549M | 520M | 560M | 551M | 504M | 493M | 426M | 385M |
| EPS (Diluted) | -7.92 | 32.92 | -3.74 | 39.12 | -32.62 | 7.51 | 28.59 | 29.97 | -0.96 | 33.35 | -15.34 | 28.56 | 9.65 | 37.93 | 19.74 | 33.78 | -3.60 | 18.34 | 14.54 | 44.29 |
| EPS Growth % | 75.72% | 338.35% | -113.08% | 30.53% | -3297.92% | -77.48% | 286.38% | 4.94% | -109.95% | -12.07% | -177.71% | -15.45% | 368.06% | 106.82% | 35.76% | -23.73% | -105.76% | -37.43% | 1027.13% | 68.08% |
| EPS (Basic) | -7.92 | 33.40 | -3.74 | 39.70 | -32.62 | 7.51 | 29.07 | 30.36 | -0.96 | 33.69 | -15.34 | 28.76 | 10.02 | 38.32 | 19.89 | 33.97 | -3.65 | 18.45 | 14.62 | 44.54 |
| Diluted Shares Outstanding | 3.12B | 3.2B | 3.15B | 3.18B | 3.16B | 3.17B | 3.22B | 3.18B | 3.14B | 3.17B | 3.13B | 3.13B | 3.23B | 3.14B | 3.13B | 3.11B | 3.15B | 3.15B | 3.16B | 3.11B |
| Basic Shares Outstanding | 3.12B | 3.16B | 3.15B | 3.13B | 3.16B | 3.17B | 3.17B | 3.14B | 3.14B | 3.14B | 3.13B | 3.11B | 3.11B | 3.11B | 3.1B | 3.09B | 3.11B | 3.13B | 3.14B | 3.09B |
| Dividend Payout Ratio | - | 147.3% | - | 116.94% | - | 611.42% | 9.99% | 145% | - | 130.77% | - | 146.26% | 33.47% | 108.28% | 18.03% | 122.72% | - | 227.54% | 20.76% | 95.89% |